로딩 중…
지수 로딩 중…
Anavex Life Sciences Corp.
AVXL· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$2.95+7.27%
2026-08-03
Financials
Valuation Metrics
Anavex Life Sciences Corp.'s Market Cap is $273M. At end of 2025 it was $317M. Ranked #2977 of 3,112 in US market (top 96%), #1343 of 1,445 on NASDAQ (top 93%), #247 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 92%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $273M | US#2,977/3,112 Sec#247/269 |
| Revenue | $0.00 | US#2,974/3,112 Sec#204/269 |
| Net Income | $-34M | US—/3,112 Sec—/269 |
| Total Assets | $129M | US#3,021/3,112 Sec#261/269 |
| Net Assets | $122M | US#2,853/3,112 Sec#218/269 |
| Value | ||
| P/B | 2.25x | US#1,323/3,112 Sec#59/269 |
| Profitability | ||
| ROE | -28.01% | US#2,604/3,112 Sec#123/269 |
| ROA | -26.47% | US#2,842/3,112 Sec#150/269 |
| Financial Health | ||
| Debt Ratio | 5.80% | US#58/3,112 Sec#25/269 |
| Total Debt | $0.00 | US—/3,112 Sec—/269 |
| Cash | $127M | US#2,050/3,112 Sec#159/269 |
| Current Ratio | 18.24x | US#136/3,112 Sec#38/269 |
| Performance | ||
| 1Y Return | -73.66% | US#3,099/3,112 Sec#266/269 |
| 1M Return | 6.88% | US#778/3,112 Sec#31/269 |
| From 52W High | -74.79% | US#3,057/3,112 Sec#259/269 |
| 1Y MDD | -82.55% | US#3,066/3,112 Sec#263/269 |
| Trading | ||
| Volume | 1,435,365 shares | US#1,162/3,112 Sec#111/269 |
| Trading Value | $4M | US#2,731/3,112 Sec#225/269 |
| Per Share | ||
| EPS | $-0.45 | US—/3,112 Sec—/269 |
| BPS | $1.42 | US#2,574/3,112 Sec#191/269 |